$IMMB Please Read Key Post( Edited Feb.8th ) As you can

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

$IMMB Please Read Key Post( Edited Feb.8th ) >> As you can see the market here is wide open for growth and by  2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB!

Why is that important to IMMB,  there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.

Well here is my take as to WHY you should BUY IMMB....

IMMB currently carries 4 patents one of which is the coveted HIV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create key patents...  IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on  October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .

Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!

As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news

Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients

Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >>  http://www.otcmarkets.com/stock/IMMB/news

Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines

Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >>  http://ih.advfn.com/p.php?pid=nmona&article=56128728

Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

A Follow up to the newly appointed Dimitrov >>  http://ih.advfn.com/p.php?pid=nmona&article=56190456

Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Company's Growth and International Expansion Plan

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T,  We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE...

KEY STATEMENTS FORM LAST PR >>

Immunotech President Harry Zhabilov commented, "We are very pleased to announce the appointment of Valentin to the Board of Directors and feel he will be a  valuable member of our team, and significantly help accelerate the progression of the company towards FDA approval for the 'IPF' technology. "

The appointment of Mr. Dimitrov to Immunotech's Board of Directors helps with the potential goal of upgrading the company to the NASDAQ exchange, where a minimum of 5 Board Members are required .

From the 2ND last PR and in the words of MR.BO LINTON (read BOLD)>>

Mr. Linton further commented the company recently  received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug" If confirmed the initial order would be in excess of several Million Dollars This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

Now that you are seeing what I am seeing I will show you the KICKER >>

CURRENT SHARE STRUCTURE

OUTSTANDING SHARES 60,500,000 give or take a handful

FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >>  http://www.otcmarkets.com/stock/IMMB/news

AUTHORIZED 150,000,000 (MAY BE HIGHER)

Want More, I have more >>

INSIDERS HOLDINGS 98% of O/S Here is the PROOF >>

Name of Shareholder Number of Shares

Harry Zhabilov 24,895,646 41.11

Ara Ghanime 24,895,646 41.11

Dow Jones Link 2,773,500 4.58

Allie Chang 600,000 1.0

Paul Felizian 600,000 1.0

Lord George Equities 5,400,000 9.0

Joseph Pittera 250,000 0.41

Harout Tovmasyan 151,000 0.25

Elie Sakayan 50,000 0.08

Hagop Parseghian 600,000 1.0

Others 339,896 0.46

So there you have it!

PS since last Wednesday JAN.30TH in case you missed it we have seen 587,375 Shares TRADED or for the most part BOUGHT and we are up from .06 to .39 with MAJOR NEWS PENDING....with that said we have seen  MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM!

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 2

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 3

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 1

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 2

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 7

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 6

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 6

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 5

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Thrill of the 33rd UAE President Cup Event

Updated Category News Views 186

The Anticipation of the 33rd UAE President Cup Abu Dhabi Turf Club is gearing up for the highly anticipated 33rd edition of the President of the UAE Cup for Arabian Purebred Horses. Scheduled during the vibrant 2025–2026 season, this event shines a light on the rich culture and love for Arabian horses. The race will take place under the esteemed patronage of His...

Continue Reading
Dover Expands Product Line with Dryer Technology Acquisition

Updated Category News Views 147

Dover Expands Product Line with Dryer Technology Acquisition Dover, a notable player in the global manufacturing sector, recently announced a strategic acquisition centered on enhancing its technological capabilities. The company, which trades on the New York Stock Exchange under the ticker symbol DOV, has taken a significant step by acquiring specific assets from Carter...

Continue Reading
Gentex Corporation Secures Air Force Contract for Night Spectacles

Updated Category News Views 135

Gentex Corporation Awarded USAF Contract Gentex Corporation, a prominent name in personal protection and situational awareness solutions, has made significant strides with its latest achievement. The company recently received a contract to develop and produce the Aircrew Laser Eye Protection (ALEP) Night Spectacle for the United States Air Force. This contract marks an...

Continue Reading
Hyster-Yale Increases Dividend to Shareholders in Announcement

Updated Category News Views 145

Hyster-Yale Declares Increased Quarterly Dividend Hyster-Yale, Inc. (NYSE: HY) recently revealed that its Board of Directors has approved a rise in the regular cash dividend from 35 cents to 36 cents per share. This increase reflects the company’s commitment to providing value to its shareholders. Details of the Dividend Payment The increased dividend will be applicable...

Continue Reading
MediWound Enhances Production Capacity with New Facility

Updated Category News Views 141

MediWound Expands Manufacturing Capacity for NexoBrid MediWound Ltd., a pioneering company in the field of enzymatic therapeutics, has successfully completed the important commissioning process for its extended GMP manufacturing facility. This advancement marks a significant moment for the organization, setting the stage for achieving a remarkable sixfold increase in...

Continue Reading